Ranks distinct AI gain and problem claims from the published record. Scores reward impact, independent source strength, scale, confidence, and recency.
Between 2010 and 2020, 124 patients with early-stage peripheral non-small cell lung cancer treated with carbon-ion radiotherapy at a single institution were analyzed retrospectively to develop a machine learning predictor of local recurrence within 24 months. An Extreme Gradient Boosting classifier trained on clinical parameters with nested threefold cross-validation achieved ROC-AUC 0.622 and PR-AUC 0.145, and separated patients into low-risk and high-risk groups.
Researchers tested Inflammacheck, a point-of-care device that measures hydrogen peroxide in exhaled breath condensate plus physiological signals, combined with machine learning, in 34 participants from a UK lung health check programme where 83% of cancers were stage I-II. Multivariate analyses separated cancer and control groups, and a voting ensemble achieved 85.7% accuracy and 0.90 ROC-AUC on held-out data.
By August 2026, researchers had trained machine learning models on ADNI data to predict tau PET positivity from more accessible MRI and amyloid PET features, then tested them on OASIS-3 and SCAN cohorts. Logistic regression reached AUCs of 0.92 in both internal and external validation, with combined external accuracy of 85%.
On July 28, 2026, Scientific Reports published a framework for adaptive level modification that continuously infers player skill and restructures game content in real time. The system combines reinforcement learning agents and human data to classify skill, then uses a two-stage large language model pipeline to rewrite level chunks, with a physics-constrained verifier to preserve playability.
In a July 2026 peer-reviewed study, 57 first-year medical students completed 24 paired clinical and foundational questions during a pediatric nephrology and urology case-based session, answering individually, then viewing a ChatGPT-generated answer that was deliberately correct or incorrect, and re-answering.
In a structured stress test published February 23, 2026, researchers evaluated ChatGPT Health, OpenAI's consumer health tool launched in January 2026, using 60 clinician-authored vignettes across 21 clinical domains under 16 factorial conditions to generate 960 responses, assessing triage recommendations and contextual sensitivity.
By June 2026, researchers tested how telecom transmission affects human detection of cloned speech. They created natural and ElevenLabs-synthesized utterances from nine speakers, processed them through simulated GSM, VoLTE, and VoIP codecs, and asked 95 participants to classify them as human or synthetic.
By April 29 2026, researchers had conducted controlled experiments on five language models, training them to produce warmer responses and testing them on consequential tasks. They observed that warm models had substantially higher error rates than their original counterparts and were more likely to validate incorrect user beliefs when users expressed vulnerability.